SCHEMBL1824975

SCHEMBL1824975

CC(C)(C)OC(=O)N=C(NCCCNC(=O)NCc1ccc(Cl)c(Cl)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
PYGL P06737 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
STK17B O94768 1/20 0.36
STK17A Q9UEE5 1/20 0.36
APEX1 P27695 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1817391 0.86 TSHR (0.57) TSHRSMN1; SMN2CA1CA2GAA
SCHEMBL19639292 0.80 TSHR (0.44) TSHRSMN1; SMN2CA1CA2GAA
SCHEMBL3443844 0.75 TDP1 (0.53) CA1CA2GAASTK17BSTK17A
SCHEMBL13107853 0.75 TDP1 (0.53) CA1CA2GAASTK17BSTK17A
SCHEMBL12401895 0.75 CA2 (0.53) SMN1; SMN2CA1CA2NR1H4
SCHEMBL30981945 0.74 SCD (0.41) TSHRSMN1; SMN2GAAMEN1KMT2A
SCHEMBL8381191 0.74 ESRRG (0.48) CA1CA2TRPV1
SCHEMBL12655254 0.74 TSHR (0.57) TSHRSMN1; SMN2HPGDLMNAHRH3
SCHEMBL991815 0.74 TDP1 (0.54) TSHRCA1CA2GAALMNA
SCHEMBL18257735 0.73 CA1 (0.47) CA1CA2GAANR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060395-A1 CYCLIC UREAS USEFUL AS HIV INHIBITORS SCHERING CORPORATION (US) 2011-05-19 WO disclosed